HKD 4.57
(5.79%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 310.32 Million HKD | 11.61% |
2022 | 278.05 Million HKD | -36.16% |
2021 | 435.57 Million HKD | 83.48% |
2020 | 237.39 Million HKD | -30.86% |
2019 | 343.34 Million HKD | 29.56% |
2018 | 265 Million HKD | 28.3% |
2017 | 206.54 Million HKD | 20.14% |
2016 | 171.92 Million HKD | 29.55% |
2015 | 132.7 Million HKD | 33.29% |
2014 | 99.56 Million HKD | 32.56% |
2013 | 75.1 Million HKD | 46.28% |
2012 | 51.34 Million HKD | 31.65% |
2011 | 39 Million HKD | 25.01% |
2010 | 31.19 Million HKD | 50.5% |
2009 | 20.73 Million HKD | -34.79% |
2008 | 31.78 Million HKD | 138.35% |
2007 | 13.33 Million HKD | 376.8% |
2006 | 2.79 Million HKD | -36.05% |
2005 | 4.37 Million HKD | -42.54% |
2004 | 7.61 Million HKD | 138.32% |
2003 | -19.86 Million HKD | -311.29% |
2002 | -4.82 Million HKD | -303.89% |
2001 | 2.36 Million HKD | 49.13% |
2000 | 1.58 Million HKD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 156.54 Million HKD | 0.0% |
2023 Q2 | 188.52 Million HKD | 0.0% |
2023 FY | 310.32 Million HKD | 11.61% |
2023 Q4 | 127.93 Million HKD | 0.0% |
2022 FY | 278.05 Million HKD | -36.16% |
2022 Q2 | 145.01 Million HKD | 0.0% |
2022 Q4 | 127.95 Million HKD | 0.0% |
2021 Q2 | 175.96 Million HKD | 0.0% |
2021 FY | 435.57 Million HKD | 83.48% |
2021 Q4 | 227.17 Million HKD | 0.0% |
2020 Q2 | 43.95 Million HKD | 0.0% |
2020 Q4 | 162.82 Million HKD | 0.0% |
2020 FY | 237.39 Million HKD | -30.86% |
2019 FY | 343.34 Million HKD | 29.56% |
2019 Q4 | 186.54 Million HKD | 0.0% |
2019 Q2 | 133.51 Million HKD | 0.0% |
2018 Q2 | 122.78 Million HKD | 0.0% |
2018 FY | 265 Million HKD | 28.3% |
2018 Q4 | 152.89 Million HKD | 0.0% |
2017 FY | 206.54 Million HKD | 20.14% |
2017 Q4 | 105.5 Million HKD | 0.0% |
2017 Q2 | 94.08 Million HKD | 0.0% |
2016 Q2 | 72.78 Million HKD | 0.0% |
2016 FY | 171.92 Million HKD | 29.55% |
2016 Q4 | 91.91 Million HKD | 0.0% |
2015 Q2 | 67.28 Million HKD | 0.0% |
2015 Q4 | 65.14 Million HKD | 0.0% |
2015 FY | 132.7 Million HKD | 33.29% |
2014 Q4 | 60.25 Million HKD | 0.0% |
2014 Q2 | 39.1 Million HKD | 0.0% |
2014 FY | 99.56 Million HKD | 32.56% |
2013 FY | 75.1 Million HKD | 46.28% |
2013 Q4 | 38.37 Million HKD | 0.0% |
2013 Q2 | 36.51 Million HKD | 0.0% |
2012 FY | 51.34 Million HKD | 31.65% |
2012 Q4 | - HKD | 0.0% |
2012 Q2 | - HKD | 0.0% |
2011 Q2 | - HKD | 0.0% |
2011 Q4 | - HKD | 0.0% |
2011 FY | 39 Million HKD | 25.01% |
2010 FY | 31.19 Million HKD | 50.5% |
2010 Q2 | 8.31 Million HKD | 0.0% |
2009 Q2 | 6.26 Million HKD | 0.0% |
2009 FY | 20.73 Million HKD | -34.79% |
2008 FY | 31.78 Million HKD | 138.35% |
2007 FY | 13.33 Million HKD | 376.8% |
2006 FY | 2.79 Million HKD | -36.05% |
2005 FY | 4.37 Million HKD | -42.54% |
2004 FY | 7.61 Million HKD | 138.32% |
2003 FY | -19.86 Million HKD | -311.29% |
2002 FY | -4.82 Million HKD | -303.89% |
2001 FY | 2.36 Million HKD | 49.13% |
2000 FY | 1.58 Million HKD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Pak Fah Yeow International Limited | 143.01 Million HKD | -116.996% |
Grand Pharmaceutical Group Limited | 2.66 Billion HKD | 88.348% |
Extrawell Pharmaceutical Holdings Limited | -8.16 Million HKD | 3902.13% |
Wai Yuen Tong Medicine Holdings Limited | 40.88 Million HKD | -659.124% |
Qianhai Health Holdings Limited | -52.18 Million HKD | 694.695% |
Lee's Pharmaceutical Holdings Limited | 36.04 Million HKD | -761.023% |
Tongfang Kontafarma Holdings Limited | - HKD | -Infinity% |
PuraPharm Corporation Limited | -66.04 Million HKD | 569.869% |
SSY Group Limited | 1.63 Billion HKD | 81.065% |
JBM (Healthcare) Limited | 174.2 Million HKD | -78.141% |
Jacobson Pharma Corporation Limited | 333.12 Million HKD | 6.843% |
China Resources Pharmaceutical Group Limited | 12.14 Billion HKD | 97.445% |